Epivir and Diplopia - a phase IV clinical study of FDA data

Summary:

Diplopia is reported as a side effect among people who take Epivir (lamivudine), especially for people who are male, 50-59 old, have been taking the drug for 6 - 12 months also take Zerit, and have Acquired immunodeficiency syndrome.

The phase IV clinical study analyzes which people have Diplopia when taking Epivir. It is created by eHealthMe based on reports of 16,823 people who have side effects when taking Epivir from the FDA, and is updated regularly.

What is Epivir?

Epivir has active ingredients of lamivudine. It is often used in hiv infection. eHealthMe is studying from 16,870 Epivir users. Check the latest studies of Epivir.

What is Diplopia?

Diplopia (double vision) is found to be associated with 1,427 drugs and 1,895 conditions by eHealthMe. Check the latest studies of Diplopia.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.

On Sep, 01, 2026

16,823 people reported to have side effects when taking Epivir.
Among them, 28 people (0.17%) have Diplopia.

Among these 28 people:

How long have people been on Epivir when they have Diplopia? *

What is the gender of people who have Diplopia when taking Epivir? *

female: 7.14 %
male: 92.86 %

What is the age of people who have Diplopia when taking Epivir? *

What are other drugs people take besides Epivir? *

What are other side effects people have besides Diplopia? *

Nausea (feeling of having an urge to vomit): 7 people, 25.00%
Vith Nerve Paralysis: 4 people, 14.29%
Anorexia (eating disorder characterized by immoderate food restriction and irrational fear of gaining weight): 4 people, 14.29%
Urinary Retention (the inability to completely or partially empty the bladder): 4 people, 14.29%
Hallucination, Auditory (perceiving sounds without auditory stimulus): 4 people, 14.29%
High Blood Cholesterol: 4 people, 14.29%
Memory Loss: 4 people, 14.29%
Blood Lactic Acid Increased: 4 people, 14.29%
Weight Decreased: 3 people, 10.71%
General Physical Health Deterioration (weak health status): 3 people, 10.71%

What are the existing conditions these people have? *

Acquired Immunodeficiency Syndrome (disease of the human immune system caused by the human immunodeficiency virus (hiv)): 4 people, 14.29%
Febrile Neutropenia (fever with reduced white blood cells): 3 people, 10.71%
Immunodeficiency Disorders: 1 person, 3.57%
Hiv Test Positive: 1 person, 3.57%

* Approximation only. Some reports may have incomplete information.

Do you take Epivir and have Diplopia?

- Check whether Diplopia is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Epivir:

Epivir (16,870 reports)

Diplopia treatments and more:

Diplopia (32,466 reports)

Browse all side effects of Epivir:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Diplopia:

Diplopia (1,427 drugs)

Browse all the conditions that are associated with Diplopia:

Diplopia (1,895 conditions)

Related publications that referenced our studies

Kocamaz, M., & Karadag, O., "Topiramate-Induced Acute Myopia, Diplopia, and Photosensitivity: A Case Report", Beyoglu Eye Journal, 2019 Jan .
Kocamaz, M., & Karadag, O., "Topiramate-Induced Acute Myopia, Diplopia, and Photosensitivity: A Case Report", Beyoglu Eye Journal, 2019 Jan .

How the study uses the data?

The study uses data from the FDA. It is based on lamivudine (the active ingredients of Epivir) and Epivir (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.